Kraig Biocraft Laboratories, Inc. to Host Shareholder Conference Call, Regarding Product, Scientific and Commercialization Developments

LANSING, MI--(Marketwire - December 02, 2011) - Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (PINKSHEETS: KBLB) announces that the Company will host an upcoming conference call to discuss product, scientific and commercialization developments. The conference call schedule is being worked around the holiday and is tentatively scheduled for the first or second week of January, and will feature the Company’s founder and CEO, Kim Thompson.

The Company recently announced that it has succeeded in creating seven new strains of genetically modified silkworm using zinc finger nuclease technology. Those new transgenics are expected to become the basis for the Company’s new platform technology.

“The pace of discovery and invention in the laboratory has been accelerating due to our successful integration of zinc finger technologies,” said Thompson.

“We are eager to update our textile and business community as to these developments and what they mean for our commercialization pipeline. We will also discuss significant commercialization and corporate developments, and strategies for the coming year.”

Additional topics include the recent breakthrough with zinc finger nuclease technology, as well as the status of other second generation spider-silk developments.

The Company will release the conference call details, including time, date and medium, in an upcoming Company release.

Shareholders are invited to submit questions to benh@ttfsco.com.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com) is a fully reporting biotechnology company that has achieved a series of scientific breakthroughs with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “develops,” “researching,” “research,” “potential,” “could” or other words or phrases of similar import. Similarly, statements in this release that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company’s financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.